Clover Health is trading at $4.53, up 5.59% in pre-market; no fresh company-specific announcement has been found to explain the gain, and its direct cause remains unconfirmed. - Major U.S. indices are higher, providing a broader supportive backdrop. - Clover Health is scheduled to report Q3 2026 results after the market closes on November 4, with its earnings call at 5:00 p.m. ET. - Needham’s Buy initiation was reported October 28, not a new November 4 catalyst.